Botox Market By Type (Botulinum Toxin Type-A and Botulinum Toxin Type-B), By End-use (Therapeutic Use and Aesthetic Use), and By Region – Trends, Analysis, and Forecast till 2030

Botox Market accounted for USD 5.15 Billion in 2020 and is estimated to be USD 10.60 Billion by 2030 and is anticipated to register a CAGR of 7.50%.

Botox is a neurotoxic protein produced during reproduction process by the bacterium Clostridium botulinum and related species. Botox is a polypeptide which has a molecular weight of 150kD and is also one of the most poisonous natural proteins. Botox is very easy to produced, purified and refined due to its stable property. Botox has wide application in experimental research and clinical applications. Botox may be a protein made up of neurotoxin, which the bacterium botulinus produces. This is often an equivalent toxin that causes botulism. Botox may be a toxin, but when doctors use it correctly and in small doses, it can have benefits. It’s both cosmetic and medical uses. As a cosmetic treatment, Botox injections can reduce the looks of skin wrinkles. Also, the Food and Drug Administration (FDA) have approved it as a treatment for various health issues, including eyelid spasms, excessive sweating, some bladder disorders, and migraine.

• Surging demand for minimally invasive treatment

Escalating population aging between 25 years to 65 years to age, surging demand for minimally invasive treatment and escalating therapeutic utility of botulinum toxin are the major driving factors of the botox market.

• Heavy investment on R&D projects

In addition, heavy investment on R&D projects to develop the therapeutic use of botox is creating numerous opportunities in the global market across the globe. Botox is more financially viable for patients, patients may notice the results of botox immediately, botox injections are less invasive than other cosmetic procedures, and it is a versatile treatment. These benefits are expected to fuel the demand of the global market over the forecast period.

• Side effects

However, side effects such as allergic reactions, rash, neck and back pain, difficulty in swallowing, shortness of breath and nausea is one of the major restraining factors of the global market across the globe. Moreover, high cost entailed in performing such expensive procedures, and poor reimbursement coverage for product is also hindering the market growth of the global market

Botox market is segmented based on type, end-use, and region.

On the basis of type, the global market is segmented into botulinum toxin type-A and botulinum toxin type-B. The botulinum toxin type-A segment held a prominent share of the global botulinum toxin market in 2018. Increase in prevalence of cervical dystonia, spasticity, glabellar lines, and crow’s foot and rise in the use of botulinum toxin type-A are key factors propelling the global market.  Based on end-use, the target market is bifurcated into therapeutic use and aesthetic use. The therapeutics end-use segment dominates the global market, owing to global rise in the cases of migraine and increase in the demand for non-surgical therapeutic procedure, which is noninvasive or minimally invasive in nature.

Regional Insights:

For detailed understanding of market dynamics, on the basis of region, the botox market is segmented into North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. North America is the largest supplier of botox, and dominates the botox market, owing to the rise in awareness level regarding non-surgical esthetic and therapeutic procedures. The global market in North America is expected to maintain its dominant position over the forecast period. The global market in Europe is the second largest supplier of botox, and is expected to expand over the forecast period, due to increase in geriatric population. The global market in Asia Pacific is projected to expand over the forecast period, owing to the rise in adoption of non-surgical botulinum toxin procedures by the geriatric population and favorable government regulations.  

Detailed Segmentation:

Botox Market, By Region:

• North America
  • Middle East & Africa
    • Middle East & Africa Botox Market, By Type
    • Middle East & Africa Botox Market, By End-User
    • Middle East & Africa Botox Market, By Country
      • GCC
      • Israel
      • South Africa
      • Rest of Middle East & Africa
  • Latin America
    • Latin America Botox Market, By Type
    • Latin America Botox Market, By End-User
    • Latin America Botox Market, By Country
      • Brazil
      • Mexico
      • Rest of Latin America
  • Asia Pacific
    • Asia Pacific Botox Market, By Type
    • Asia Pacific Botox Market, By End-User
    • Asia Pacific Botox Market, By Country
      • China
      • India
      • Japan
      • South Korea
      • Rest of Asia Pacific
  • North America Botox Market, By Type
  • North America Botox Market, By End-User
  • North America Botox Market, By Country
    • Canada
    • Europe
  • Europe Botox Market, By Type
  • Europe Botox Market, By End-User
  • Europe Botox Market, By Country
    • Germany
    • UK
    • France
    • Russia
    • Italy
    • Rest of Europe

The key players operating in the botox market includes Allergan, Inc., Ipsen Group, Merz Pharma GmbH & Co. KGaA, Medytox, Inc., US Worldmed, LLC, Metabiologics, Inc., Lanzhou Institute of Biological Products Co. Ltd., Revance Therapeutics, Inc., Allergan, Inc., Ipsen Group, and Merz Pharma GmbH & Co. Advancements in the product as well as in manufacturing process, product launches, and strategic partnerships are some trends witnessed in the Botox Market.

• Allergan, Inc.
• Ipsen Group
• Merz Pharma GmbH & Co. KGaA
• Medytox, Inc.
• US Worldmed
• Metabiologics, Inc.
• Lanzhou Institute of Biological Products Co. Ltd.
• Revance Therapeutics, Inc.
• Allergan, Inc.
• Ipsen Group